Læknablaðið : fylgirit - 01.05.1978, Qupperneq 17

Læknablaðið : fylgirit - 01.05.1978, Qupperneq 17
Heinola Study Group^) FOLLOW-UP SURVEY OF ARTHRITIS, HEINOLA In 1971, on Prof. Veikko Laine’s initiative, planning of a long-term research program for the Rheumatism Foundation Hospital was started. Because of practical reasons a clinical follow-up survey was chosen. The project started in 1973, and the sampling of the patient material lasted two years. In this paper some basic features of the survey will be presented. The study is financially supported by the Finnish Academy of Sciences and the Social Insurance Institution of Finland. The main goals of this interdisciplinary project are definitions of prognostically important medical, social and psychological signs, diagnostic criteria at the early stage of the inflammatory joint disease, etiological factors of the arthritis as well as the benefits and costs of the treatment. The area from which we get our patients for the study includes five towns and the surrounding countryside. The population of this area is 360.000. All physicians working in the area are informed many times by letters and announcements. They are asked to send to our hospital patients who fulfil the following criteria: 1. age 16 years or more 2. swelling of at least one joint 3. joint swelling has not lasted more than six months Our hospital collects the patients, makes clinical, radiological and routine laboratory examinations, takes blood and tissue samples and sends them to research laboratories for analysis. All data is treated in a form suitable for com- puters. Altogether we co-operate with seven institutes, and the whole group includes 26 scientists. x) Isomáki H, Ahlqvist J, Aho K. Ahvonen P, v. Essen R, Jansson E, Kajander A, Kiviniemi P, Koota K, Laine V, Larsen A, Laurinkari J, Martio J, Makisara G-L, Makisara P, Nissila M, Nuotio P, Penttinen K, Raunio J, Raunio P, Rimon R, Rasánen J, Sarna S, Tiilikainen A, Wager O, Vainio K. RESULTS During two years we received totally 446 patients. In addition, 11 patients have been accepted later, so that total patient material includes 457 arthritie patients, whose disease has not lasted more than six months when first seen in our hospital. The incidence of arthritis was about 1 %o in a year in population over 16 years. This is far to low. We have studied the situation more precisely in Heinola. Dr. Juha Raunio obtained an incidence of-2.1%o in Heinola in 1974. Also this incidence probably is too low. It seems almost impossible to get the true incidence of beginning arthritis by a passive sampling method. The first diagnosis, which doesn’t mean the final diagnosis in chronic cases, was probable RA in 147o, definite RA in 33% (together 47%), ankylosing spondylitis only in 47o because of the criteria for the study which required swelling of a joint, Reiter’s disease in 9%, reactive post- infectious arthritis in 8%, non defined arthritis (mostly of one knee joint) in 197o, 11 patients with psoriatic arthritis, 1 patient with rheumatic fever, 7 patients with gouty arthritis, 6 patients with osteoarthritic joint swelling, 5 patients with acute sarcoidosis, 8 patients with systemic connective tissue disease, and 28 patients with other joint diseases. The low frequency of rheumatic fever and the high frequency of non defined arthritis are remarkable. The sex distribution shows that females dominate especially in RA. Only in the disease-group of ankylosing spondylitis, Reiter’s disease and reactive postinfectious arthritis ("HLA B 27 disease") females are in minority. The clinical picture of the arthritis in younger , age-groups was not so often rheumatoid arthritis than in the eldest age group, where 73 per cent of all patients were first classified as rheumatoid arthritis and only 1 female patient as reactive postinfectious arthritis. The HL-A antigens have been typed in 272 patients. The frequency of the HLA B 27 was 30% in RA, 83% in ankylosing spondylitis, 66% in Reiter’s disease, 89% in reactive postinfectious arthritis, 29% in psoriatic arthritis, 38% in non defined arthritis, 18% in other joint diseases 15
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72
Qupperneq 73
Qupperneq 74
Qupperneq 75
Qupperneq 76
Qupperneq 77
Qupperneq 78
Qupperneq 79
Qupperneq 80
Qupperneq 81
Qupperneq 82
Qupperneq 83
Qupperneq 84
Qupperneq 85
Qupperneq 86
Qupperneq 87
Qupperneq 88
Qupperneq 89
Qupperneq 90
Qupperneq 91
Qupperneq 92
Qupperneq 93
Qupperneq 94
Qupperneq 95
Qupperneq 96
Qupperneq 97
Qupperneq 98
Qupperneq 99
Qupperneq 100
Qupperneq 101
Qupperneq 102
Qupperneq 103
Qupperneq 104
Qupperneq 105
Qupperneq 106
Qupperneq 107
Qupperneq 108
Qupperneq 109
Qupperneq 110
Qupperneq 111
Qupperneq 112
Qupperneq 113
Qupperneq 114
Qupperneq 115
Qupperneq 116
Qupperneq 117
Qupperneq 118
Qupperneq 119
Qupperneq 120
Qupperneq 121
Qupperneq 122
Qupperneq 123
Qupperneq 124
Qupperneq 125
Qupperneq 126
Qupperneq 127
Qupperneq 128
Qupperneq 129
Qupperneq 130
Qupperneq 131
Qupperneq 132
Qupperneq 133
Qupperneq 134
Qupperneq 135
Qupperneq 136
Qupperneq 137
Qupperneq 138
Qupperneq 139
Qupperneq 140
Qupperneq 141
Qupperneq 142
Qupperneq 143
Qupperneq 144
Qupperneq 145
Qupperneq 146
Qupperneq 147
Qupperneq 148
Qupperneq 149
Qupperneq 150
Qupperneq 151
Qupperneq 152
Qupperneq 153
Qupperneq 154
Qupperneq 155
Qupperneq 156
Qupperneq 157
Qupperneq 158

x

Læknablaðið : fylgirit

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið : fylgirit
https://timarit.is/publication/991

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.